Last $0.34 USD
Change Today -0.0108 / -3.11%
Volume 24.5K
As of 10:37 AM 07/23/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Susan S. Wang

Independent Director and Chairman of Audit Committee, Nektar Therapeutics
AgeTotal Calculated CompensationThis person is connected to 48 board members in 3 different organizations across 9 different industries.

See Board Relationships
63$390,930

Background*

Ms. Susan S. Wang served as the Chief Financial Officer, Executive Vice President of Corporate Development and Corporate Secretary at Solectron Corporation. Ms. Wang retired from Solectron in June 2002 and has held several key positions during her 18 years. She is a Financial Expert. Before joining Solectron in 1984, Ms. Wang held financial and managerial positions with Xerox Corporation , Westvaco Corporation, Price Waterhouse LLP and Price Waterhouse & Co. She has ...

Read Full Background

Corporate Headquarters*

9 Xinhua Road
Wuxi, Jiangsu Province 214028

China

Phone: 86 21 6288 5574
Fax: 86 21 6288 5574

Board Members Memberships*

2002-2009
Former Director, Chairman of Audit Committee and Member of Compensation Committee
2003-2013
Former Director and Chairman of Audit Committee
2003-Present
Independent Director and Chairman of Audit Committee
2003-N/A
Former Independent Director, Chairman of Audit Committee and Member of Executive Committee
2009-2011
Former Independent Director and Chairman of Audit Committee
2009-2013
Former Chairwoman and Member of Audit Committee
2011-Present
Director, Chairperson of Audit Committee and Member of Compensation Committee
2013-Present
Independent Director, Chairman of Audit Committee and Member of Member Agreement Review Committee

Education*

BBA 1972
The University of Texas System
MBA 1981
University of Connecticut

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$89,750
Total Calculated Compensation$390,930
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
STPFQ:US $0.34 USD -0.0108

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Peter M. Hecht Ph.D. Co-Founder, Chief Executive Officer and Director
Ironwood Pharmaceuticals, Inc.
$100.0K
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
$590.6K
Peter William Grant Chief Executive Officer and Executive Director
SkyePharma plc
567.0K GBP
William J. Polvino M.D.Chief Executive Officer and President
Veloxis Pharmaceuticals A/S
--
Daniel J. Abdun-Nabi Chief Executive Officer, President, Director and Member of Strategic Operations Committee
Emergent BioSolutions, Inc.
$1.0M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SUNTECH POWER HOLDINGS-ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.